NAD+ 500mg — Verification Report
From NorthStar Compounds · Lot SGX-NC-2026-0622-G16 · Tested July 2026
VialTalk
NAD+ 500mg
NorthStar Compounds
Score
85
Grade
B
Good
Lot SGX-NC-2026-0622-G16
Tested July 2026
Report ID
edae8168
Test
Method
Result
Status
PurityFull credit
HPLC
99.07%
Full credit
IdentityFull credit
Mass spectrometry
Confirmed
Full credit
ContentFull credit
Gravimetric vs label claim
500 mg labeled · 507.43 mg tested
Full credit
EndotoxinNot submitted
Not tested
Not tested
Not submitted
Heavy metalsNot submitted
Not tested
Not tested
Not submitted
SterilityNot submitted
Not tested
Not tested
Not submitted
Batch conformityNot submitted
Not tested
Not tested
Not submitted
Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted.
This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →
Canonical source: https://vialtalk.com/vendors/northstar-compounds/coas/edae8168-f7d1-4fd1-9ab1-456fbad98a16
